
Protom International, Inc.: A leading manufacturer of proton therapy technology for cancer treatment.
Protom International, Inc., founded with the mission to revolutionize cancer treatment, focuses on expanding the accessibility of proton therapy. The company offers the Radiance 330® Proton Therapy System, a compact and modular solution designed to address challenges in cancer therapy. Protom International aims to make advanced proton therapy more economically viable and accessible to healthcare providers, primarily serving markets in Texas and Massachusetts.
Notable figures affiliated with Protom International include experts in medical technology and oncology. The company has achieved significant milestones, including the development and deployment of its innovative Radiance 330® system. Protom International's impact is evident in its contribution to making cutting-edge cancer treatment more accessible, thereby improving patient outcomes and advancing the field of proton therapy.
Proton Therapy USA

ProNova Solutions

Proton Treatment and Research Center
protons.com

Mevion Medical Systems
mevion.com

Privo Technologies

Core Oncology

Proterixbio

Promaxo
promaxo.com

bioProtonics
bioprotonics.com

Proteotech

Ionix Medical

Bragg Peak Systems
braggpeak.com

Proa Medical
proamedical.com

ProstaGene

ViewRay
Companies similar to Protom International include Proton Therapy USA, ProNova Solutions, Proton Treatment and Research Center and Mevion Medical Systems.
Protom International was founded in 2008.
Protom International's headquarters is located in Flower Mound, TX, US.
Protom International's most recent funding round was for $30M (USD) in April 2017.
As of Apr 7, 2017, Protom International has raised a total of $31.8M (USD).
Protom International has 40 employees as of Feb 5, 2024.